Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP451326.RARWQZJcevWLcnndKTvRtt_f6XSHFgbrk-sBUyoUJ7nbU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP451326.RARWQZJcevWLcnndKTvRtt_f6XSHFgbrk-sBUyoUJ7nbU130_assertion type Assertion NP451326.RARWQZJcevWLcnndKTvRtt_f6XSHFgbrk-sBUyoUJ7nbU130_head.
- NP451326.RARWQZJcevWLcnndKTvRtt_f6XSHFgbrk-sBUyoUJ7nbU130_assertion description "[Our data suggest that Livin/ML-IAP may be an excellent target antigen in immunotherapy for lung cancer and Livin7 peptide may serve as a potent peptide vaccine for HLA-A*2402(+)/Livin(+) lung cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP451326.RARWQZJcevWLcnndKTvRtt_f6XSHFgbrk-sBUyoUJ7nbU130_provenance.
- NP451326.RARWQZJcevWLcnndKTvRtt_f6XSHFgbrk-sBUyoUJ7nbU130_assertion evidence source_evidence_literature NP451326.RARWQZJcevWLcnndKTvRtt_f6XSHFgbrk-sBUyoUJ7nbU130_provenance.
- NP451326.RARWQZJcevWLcnndKTvRtt_f6XSHFgbrk-sBUyoUJ7nbU130_assertion SIO_000772 15709165 NP451326.RARWQZJcevWLcnndKTvRtt_f6XSHFgbrk-sBUyoUJ7nbU130_provenance.
- NP451326.RARWQZJcevWLcnndKTvRtt_f6XSHFgbrk-sBUyoUJ7nbU130_assertion wasDerivedFrom befree-20150227 NP451326.RARWQZJcevWLcnndKTvRtt_f6XSHFgbrk-sBUyoUJ7nbU130_provenance.
- NP451326.RARWQZJcevWLcnndKTvRtt_f6XSHFgbrk-sBUyoUJ7nbU130_assertion wasGeneratedBy ECO_0000203 NP451326.RARWQZJcevWLcnndKTvRtt_f6XSHFgbrk-sBUyoUJ7nbU130_provenance.